Nerve Regeneration Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2018/039017, filed Jun 22, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,766,567 | Nerve Regeneration System and Method In force · High confidence | Checkpoint Surgical, Inc. | In force | High confidence | ||
| US 11,872,401 | Nerve Regeneration Method In force · High confidence | Checkpoint Surgical, Inc. | In force | High confidence | ||
| US 12,311,178 | Nerve Regeneration System and Method In force · High confidence | Checkpoint Surgical, Inc. | In force | High confidence | ||
| Application 19/216,002 | Nerve Regeneration System and Method Pending Not granted | Checkpoint Surgical, Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Checkpoint Surgical, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.